If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

Tuesday broker round-up UPDATE

Tue, 19th Feb 2013 07:30
Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling.Advanced Medical Solutions: Investec upgrades from hold to buy with a target price of 68p.African Barrick Gold: Canaccord Genuity reduces target price from 360p to 305p keeping a hold rating.Anglo American: JP Morgan reduces target price from 1680p to 1640p and reiterates an underweight rating. UBS ups target price from 1860p to 2000p retaining a neutral rating. Societe Generale raises target price from 1700p to 1900p, while its sell recommendation is maintained.Antofagasta: Investec restarts with a target price of 958p and a sell recommendation.Beazley: Westhouse Securities ups target price from 220p to 235p and downgrades to add.Booker Group: JP Morgan initiates with a target price of 122p and an overweight rating.Bovis Home Group: Panmure Gordon downgrades to hold with a target price of 650p.Brammer: Investec raises target price from 365p to 390p retaining a buy recommendation.Cable & Wireless Communications: Deutsche Bank shifts target price from 55p to 53p reiterating a buy recommendation.Carillion: Berenberg upgrades from hold to buy.Chariot Oil & Gas: Merchant Securities reduces target price from 34.60p to 29.20p and leaves its hold recommendation unchanged.Circle Oil: Investec cuts target price from 80p to 68p, while staying with its buy recommendation.Fidessa: Credit Suisse increases target price from 1782p to 2213p and retains an outperform rating.G4S: Goldman Sachs moves target price from 232p to 242p, while keeping a strong sell recommendation.HSBC Holdings: Morgan Stanley shifts target price from 740p to 737p, downgrading to equal-weight in the process from overweight.Informa: Liberum Capital downgrades to sell with a target price of 450p.Inmarsat: Morgan Stanley takes target price from 640p to 690p, while leaving its equal-weight rating unchanged.InterContinental Hotels Group: Investec revises target price from 1950p to 2000p, while downgrading from buy to hold. Numis ups target price from 1800p to 2000p, but downgrades to hold.Ladbrokers: Investec increases target price from 165p to 250p and upgrades from hold to buy.Man Group: Credit Suisse shifts target price from 94p to 104p reiterating a neutral rating.Micro Focus International: Espirito Santo moves target price from 440p to 450p and stays with its sell recommendation.Mondi: Deutsche Bank increases target price from 640p to 930p and keeps its buy recommendation.Morgan Sindall: Panmure Gordon cuts target price from 640p to 450p and downgrades to sell.Morrison (WM): JP Morgan starts with a target price of 245p and an underweight rating.Pendragon: Jefferies moves target price from 20p to 31p maintaining a buy recommendation.Reed Elsevier: UBS revises target price from 770p to 790p, its buy recommendation is unaltered.Rolls-Royce Group: Exane BNP shifts target price from 1060p to 1075p maintaining an outperform rating.RPS Group: Jefferies raises target price from 255p to 280p and keeps a buy recommendation.RSA Insurance Group: Deutsche Bank shifts target price from 140p to 147p, while its buy recommendation is reiterated. Berenberg initiates with a buy recommendation.Sage Group: Merchant Securities shifts target price from 300p to 305p staying with its hold recommendation.Sainsbury: JP Morgan starts with a target price of 325p and an underweight rating.Severfield-Rowen: Canaccord Genuity lowers target price from 70p to 50p and reiterates a sell recommendation.Shire: JP Morgan revises target price from 2200p to 2340p retaining an overweight rating.Sinclair IS Pharma: Investec shifts target price from 38p to 37p and keeps its buy recommendation.Spirent Communications: N+1 Singer downgrades to buy with a target price of 165p.Standard Chartered: Morgan Stanley ups target price from 1656p to 1924p and upgrades to overweight.St James's Place: Barclays increases target price from 413p to 582p upgrading from equal-weight to overweight.Telecity Group: Goldman Sachs revises target price from 1110p to 1160p and retains a buy recommendation.Tesco: JP Morgan initiates with a target price of 425p and an overweight rating.Tullow Oil: Liberum Capital lowers target price from 1755p to 1683p maintaining a buy recommendation.3 Legs Resources: Northland Capital initiates with a target price of 79p and a buy recommendation.Vodafone: Sanford Bernstein downgrades to underperform with a 135p price target.

Related News

LONDON MARKET MIDDAY: Shell gains offset miners as FTSE 100 edges up
3 hours ago

LONDON MARKET MIDDAY: Shell gains offset miners as FTSE 100 edges up

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with strength in energy stocks offset by weakness in miners, while investors...

Bank of England sets out plan to ease bank leverage rules
4 hours ago

Bank of England sets out plan to ease bank leverage rules

* BoE sets out plan to ease leverage ​ratio requirements and enhance buffer usability

WINNERS & LOSERS: Shell lifts outlook; Keller will beat market view
5 hours ago

WINNERS & LOSERS: Shell lifts outlook; Keller will beat market view

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday.

Sinclair Pharma News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Weiss Asset Management More Than Doubles Sinclair Pharma Stake (ALLISS)
17 Oct 2018

Weiss Asset Management More Than Doubles Sinclair Pharma Stake (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Wednesday that Weiss Asset Management LP more than doubled its stake in the company raising it to 12...

Sinclair Pharma H1 losses widen as revenue rises
27 Sep 2018

Sinclair Pharma H1 losses widen as revenue rises

(Sharecast News) - Dermatology product maker Sinclair Pharma said first half pre-tax losses widened to £11.4m from £7.8m.

Sinclair Pharma Interim Loss Deepens On One-Off Charges, Revenue Grows
27 Sep 2018

Sinclair Pharma Interim Loss Deepens On One-Off Charges, Revenue Grows

LONDON (Alliance News) - Aesthetic dermatology firm Sinclair Pharma PLC said Thursday its interim loss deepened amid one-off costs, meanwhile revenue ...

Sinclair Pharma Takeover Moves Closer As Conditions Are Met
18 Sep 2018

Sinclair Pharma Takeover Moves Closer As Conditions Are Met

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday the pre-conditions for Huadong Medicine Aesthetics Investment (Hong Kong) Ltd's takeover hav...

LONDON MARKET OPEN: Stocks Mixed, Micro Focus Climbs On Buyback
29 Aug 2018

LONDON MARKET OPEN: Stocks Mixed, Micro Focus Climbs On Buyback

LONDON (Alliance News) - Stock prices in London were mixed early Wednesday, with Micro Focus and CRH helping the large-cap index to out-perform after ...